The company’s technology, which enables it to skip an expensive manufacturing step, could lead to vaccines that are easier to produce, said CEO Emmanuel Hanon.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,